Olema Pharmaceuticals, Inc.
OLMA
$4.26
$0.051.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.74M | 18.82M | 18.31M | 17.50M | 18.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 142.26M | 138.71M | 124.43M | 112.50M | 104.96M |
| Operating Income | -142.26M | -138.71M | -124.43M | -112.50M | -104.96M |
| Income Before Tax | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -129.47 | -122.68 | -109.63 | -99.34 | -96.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M |
| EBIT | -142.26M | -138.71M | -124.43M | -112.50M | -104.96M |
| EBITDA | -141.87M | -138.34M | -124.07M | -112.13M | -104.58M |
| EPS Basic | -2.21 | -2.19 | -2.06 | -2.02 | -2.16 |
| Normalized Basic EPS | -1.38 | -1.40 | -1.32 | -1.29 | -1.34 |
| EPS Diluted | -2.21 | -2.19 | -2.06 | -2.02 | -2.16 |
| Normalized Diluted EPS | -1.38 | -1.40 | -1.32 | -1.29 | -1.34 |
| Average Basic Shares Outstanding | 234.91M | 223.90M | 211.62M | 196.06M | 180.84M |
| Average Diluted Shares Outstanding | 234.91M | 223.90M | 211.62M | 196.06M | 180.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |